Cosmeceuticals
Cosmeceuticals have become the fastest-growing segment of the cosmetics and personal care industry.
There are three different categories of skin care products:
- “pharma-quality” dermatologist/physician formula brands;
- prestige products; and
- mass-market products.
A trend is that the cosmeceutical products with the best potential will be those that are backed by science.
All of Devonian Health Group Inc.’s skin-care products are developed by the same approach as its pharmaceutical products, with strong safety and efficacy data, which positions these products as science-based.
R-Spinasome®: a breakthrough cosmeceutical active ingredient
R-Spinasome®, Devonian Health Group Inc.’s cosmeceutical flagship ingredient, is a photosynthetic cell extract composed of pigments, proteins and lipids extracted from green leaves. The structure of this complex is critical to its function as an anti-oxidant, enabling it to capture and dissipate noxious energy generated by Reactive Oxygen Species (ROS), returning the complex to a state where it is ready to undergo new activation cycles. It is this dynamism and capacity to regenerate that provides R-Spinasome® complex with unprecedented, long lasting anti-oxidant activity. R-Spinasome® is patent-protected in Japan, Canada, United States and Europe (#JP 5952261; #CDN 2,699,6765; #US 13/261,472, #EUR 11 768 299.7).
Purgenesis™ : novel anti-aging products
The first derma-cosmeceutical products that Devonian Health Group Inc. has developed is a women’s anti-aging product line consisting of day, night, and eye creams. R-Spinasome®, Devonian Health Group Inc.’s proprietary natural active ingredient is included is these proprietary products.
In a 28-day comparison study, the product demonstrated superior anti-aging treatment effects compared with two highly regarded anti-aging prestige brands.
In a consumer panel study, more that 75% of women reported that they would switch to Devonian Health Group Inc.’s product.
The Purgenesis™ treatment now carries the seal of recognition of the Skin Health Program, awarded after a thorough review of the treatment formulation by the Canadian Association of Dermatology’s Expert Advisory Council on Skin Health.
Purgenesis™ brand : market ready pipeline of innovative products
The cosmeceutical pipeline in development includes:
-
Serum
-
Regenerating cream
For more information, on Purgenesis™ products, please consult www.purgenesis.com
References
- Carroll JM, Hanna S, Guenther LC, Boucher N. Comparison of topical antiaging creams in the management of lateral canthal lines. J Cosmet Dermatol. 2020 Mar;19(3):694-704. doi: 10.1111/jocd.13062. Epub 2019 Jul 26. PMID: 31350814; PMCID:
Link: https://pubmed.ncbi.nlm.nih.gov/31350814/